BAXTER ANNOUNCES MISSION AND LOGO FOR PROPOSED KIDNEY CARE COMPANY VANTIVE
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
Press Release PDF DEERFIELD, Ill. - 2024-05-15 Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission
Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
(BAX) - Analyzing Baxter Intl's Short Interest
Baxter Intl's (NYSE:BAX) short percent of float has risen 27.04% since its last report. The company recently reported that it has 9.68 million shares sold short, which is 2.49% of all regular shares t
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Press Release Clinolipid provides calories and essential fatty acids for parenteral nutrition Expanded indication demonstrates Baxter's continued commitment to meeting the diverse
Returns On Capital Signal Tricky Times Ahead For Baxter International (NYSE:BAX)
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach is to try and find a company with returns on capital employed (ROCE) that are inc
Baxter International's (NYSE:BAX) Dividend Will Be $0.29
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
In the latest quarter, 4 analysts provided ratings for Baxter Intl (NYSE:BAX), showcasing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings, showcasing the evol
Baxter Downgraded to Hold by TD Cowen in Wake of Selloff
Baxter International Cut to Hold From Buy by TD Cowen
Baxter International Cut to Hold From Buy by TD Cowen
Baxter Intl Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 11.86% TD Cowen → $40 Downgrades Buy → Hold 04/03/2024 23.04% Citigroup $41 → $44 Maintains Neu
TD Cowen Downgrades Baxter International to Hold From Buy, Price Target Is $40
Baxter International (BAX) has an average rating of outperform and price targets ranging from $39 to $67, according to analysts polled by Capital IQ. Price: 35.74, Change: -0.21, Percent Change: -0.58
Why the Dow Keeps Outperforming the S&P 500 This Month -- Barrons.com
By Connor Smith The Dow Jones Industrial Average has closed higher every day in May, beating out the S&P 500 for a rare stretch. How the Dow is constructed is finally helping -- rather than hurting -
Baxter International on Track for Longest Losing Streak Since October 2018 -- Data Talk
Baxter International Inc. (BAX) is currently at $35.65, down $0.10 or 0.28% --Would be lowest close since Nov. 20, 2023, when it closed at $35.62 --Currently down 11 of the past 12 days --Currently
Baxter to Present at Bank of America 2024 Health Care Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America 2024 Health Care Conference on Wednesday, May 15, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to
Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31
12:11 PM EDT, 05/07/2024 (MT Newswires) -- Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31 Price: 36.26, Change: -0.25, Percent Change:
Press Release: Baxter Declares Quarterly Dividend
Baxter Declares Quarterly Dividend DEERFIELD, Ill.--(BUSINESS WIRE)--May 07, 2024-- Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has dec
Baxter Declares Quarterly Dividend
Press Release PDF DEERFIELD, Ill. - 2024-05-07 Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Boar
Goldman's Top 50 Weak Balance Sheet Stocks
Goldman Sachs analysts listed 50 stocks constituents of their “weak balance sheet” basket.
Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 46% Undervaluation?
No Data